Michal Abrahamowicz
Research Scientist, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage
Le fondateur et directeur scientifique d’Arthrite-recherche Canada passe le relais à sa successeure.
Le fondateur et directeur scientifique d’Arthrite-recherche Canada passe le relais à sa successeure le 7 juillet 2020 (Vancouver, C. - B) – Après 21 ans à la tête d’Arthrite-recherche Canada/Arthritis Research Canada en tant que directeur scientifique, le Dr John...
Arthritis Research Funding Highlights
Arthritis Research Funding Highlights Dr. Cheryl Barnabe (Arthritis Research Canada, Alberta) is Canada’s leader in research relating to the health of the indigenous community. Dr. Barnabe as Co-Principal Investigator with Cara Bablitz, Lynden Crowshoe, Michael Green,...
Arthritis Research Canada creator and scientific director passes the baton to successor.
Arthritis Research Canada creator and scientific director passes the baton to successor July 7, 2020 (Vancouver, BC) – After 21 years as Arthritis Research Canada/Arthrite-recherche Canada’s scientific director, world-renowned scientist and rheumatologist, Dr. John...
Evaluating the safety and efficacy of biosimilars to help shape future health policies
Evaluating the safety and efficacy of biosimilars to help shape future health policies June 17, 2020 (Vancouver, BC) – Biosimilars are considered to be a safe and effective alternative to the original biologics medications in the treatment of rheumatoid arthritis...
New Research on COVID-19 and Immunosuppressive Medications May Provide Answers for People with Rheumatic Diseases.
New Research on COVID-19 and Immunosuppressive Medications May Provide Answers for People with Rheumatic Diseases June 9, 2020 (Vancouver, BC) – Are people with Rheumatic Diseases who take immunosuppressive medications at a higher risk of getting COVID-19? Do people...
Research shows hydroxychloroquine has substantial survival benefit among patients with systemic lupus erythematosus in the general population
Research shows hydroxychloroquine has substantial survival benefit among patients with systemic lupus erythematosus in the general population May 20, 2020 (Vancouver, BC) – An Arthritis Research Canada study has revealed substantial survival benefit associated with...
Arthritis Research Canada new research to address impact of COVID-19 on medication use and mental health for people with arthritis
Arthritis Research Canada new research to address impact of COVID-19 on medication use and mental health for people with arthritis May 4, 2020 (Vancouver, BC) – Arthritis Research Canada’s research scientist Dr. Mary De Vera and her team have launched a new study,...
Arthritis Research Canada/Arthrite-recherche Canada collaborates on global initiative to respond to COVID-19 Pandemic
Arthritis Research Canada/Arthrite-recherche Canada collaborates on global initiative to respond to COVID-19 Pandemic. April 15, 2020 (Vancouver, BC) – Arthritis Research Canada/Arthrite-recherche Canada is collaborating with the COVID-19 Global Rheumatology Alliance...
Arthritis Research Canada responding to the COVID-19
Arthritis Research Canada responding to the COVID-19 March 16, 2020 (Vancouver, BC) –In light of the recent developments with the COVID-19 outbreak and the changing recommendations from the governments of BC and Canada, Arthritis Research Canada is carefully...
Arthritis Research Canada/Arthritis-Recherche Canada scientists receive top honours from the Canadian Rheumatology Association
Arthritis Research Canada/Arthrite-Recherche Canada scientists receive top honours from the Canadian Rheumatology Association February 27, 2020 (Vancouver, BC): Arthritis Research Canada/Arthrite-recherche Canada scientists capture the highest accolades from the...
